Gmax Biopharm
PrivateLast Round
Series C
Mar 9, 2021
Est. Valuation
$80.52M
Total Funding Raised
$92.22M
Company Overview
Gmax Biopharm is a biopharmaceutical company that develops innovative therapeutic monoclonal antibodies targeting G-protein coupled receptors (GPCRs) for the treatment of cardiovascular, metabolic, and cancer-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gmax Biopharm Comparables
Compare Gmax Biopharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QL Biopharm | 87% | |
| Zhejiang Doer Biologics | 86% | |
| Sino Biopharmaceutical | 80% | |
Gmax Biopharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 9, 2021 | ||||
| Series B | Jan 22, 2017 | ||||
| Series A | Dec 28, 2014 | ||||
| Angel | Sep 1, 2010 |
Gmax Biopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Merchants Group | Series C |
| Zhongyuan Capital | Series C |
| Lechuanghui | Series A |
| Efung Capital | Series B |
| Cowin Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors grew 3197% MoM, reaching 5.3K.
- Jun 1, 2025
Monthly visitors increased 68% MoM, reaching 1K.
Gmax Biopharm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gmax Biopharm's valuation, stock price, and market status.